87 related articles for article (PubMed ID: 22017843)
21. Fixed-combination brimonidine-timolol versus latanoprost in glaucoma and ocular hypertension: a 12-week, randomized, comparison study.
Katz LJ; Rauchman SH; Cottingham AJ; Simmons ST; Williams JM; Schiffman RM; Hollander DA
Curr Med Res Opin; 2012 May; 28(5):781-8. PubMed ID: 22458918
[TBL] [Abstract][Full Text] [Related]
22. Control of intraocular pressure and fluctuation with fixed-combination brimonidine-timolol versus brimonidine or timolol monotherapy.
Spaeth GL; Bernstein P; Caprioli J; Schiffman RM
Am J Ophthalmol; 2011 Jan; 151(1):93-99.e4. PubMed ID: 21111399
[TBL] [Abstract][Full Text] [Related]
23. The Low-pressure Glaucoma Treatment Study (LoGTS) study design and baseline characteristics of enrolled patients.
Krupin T; Liebmann JM; Greenfield DS; Rosenberg LF; Ritch R; Yang JW;
Ophthalmology; 2005 Mar; 112(3):376-85. PubMed ID: 15745762
[TBL] [Abstract][Full Text] [Related]
24. Brimonidine and eye pressure.
Nowroozzadeh MH; Razeghinejad MR
Ophthalmology; 2010 Jul; 117(7):1463; author reply 1463-4. PubMed ID: 20610002
[No Abstract] [Full Text] [Related]
25. Comparison of the intraocular pressure-lowering effect and safety of brimonidine/timolol fixed combination and 0.5% timolol in normal-tension glaucoma patients.
Kim JM; Kim TW; Kim CY; Kim HK; Park KH
Jpn J Ophthalmol; 2016 Jan; 60(1):20-6. PubMed ID: 26578422
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for optic disc hemorrhage in the low-pressure glaucoma treatment study.
Furlanetto RL; De Moraes CG; Teng CC; Liebmann JM; Greenfield DS; Gardiner SK; Ritch R; Krupin T;
Am J Ophthalmol; 2014 May; 157(5):945-52. PubMed ID: 24513094
[TBL] [Abstract][Full Text] [Related]
27. [Effect of topical 0.1% brimonidine tartrate and 0.5% timolol maleate on pulmonary and cardiovascular functions].
Araie M; Adachi M
Nippon Ganka Gakkai Zasshi; 2012 Jul; 116(7):623-34. PubMed ID: 22844781
[TBL] [Abstract][Full Text] [Related]
28. Visual field and intraocular pressure asymmetry in the low-pressure glaucoma treatment study.
Greenfield DS; Liebmann JM; Ritch R; Krupin T;
Ophthalmology; 2007 Mar; 114(3):460-5. PubMed ID: 17141318
[TBL] [Abstract][Full Text] [Related]
29. [Phase III clinical trial of brimonidine in patients with primary open-angle glaucoma and ocular hypertension--comparison of the effects of brimonidine monotherapy versus timolol monotherapy, or combination brimonidine/prostaglandins therapy versus combination placebo/prostaglandins therapy].
Araie M; Yamazaki Y; Sugiyama K; Kuwayama Y; Tanihara H
Nippon Ganka Gakkai Zasshi; 2012 Oct; 116(10):955-66. PubMed ID: 23285843
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the anti-Acanthamoeba activity of two commercial eye drops commonly used to lower eye pressure.
Sifaoui I; Reyes-Batlle M; López-Arencibia A; Wagner C; Chiboub O; De Agustino Rodríguez J; Rocha-Cabrera P; Valladares B; Piñero JE; Lorenzo-Morales J
Exp Parasitol; 2017 Dec; 183():117-123. PubMed ID: 28778743
[TBL] [Abstract][Full Text] [Related]
31. Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trial.
Sherwood MB; Craven ER; Chou C; DuBiner HB; Batoosingh AL; Schiffman RM; Whitcup SM
Arch Ophthalmol; 2006 Sep; 124(9):1230-8. PubMed ID: 16966616
[TBL] [Abstract][Full Text] [Related]
32. 12-week study comparing the fixed combination of brimonidine and timolol with concomitant use of the individual components in patients with glaucoma and ocular hypertension.
Goñi FJ;
Eur J Ophthalmol; 2005; 15(5):581-90. PubMed ID: 16167288
[TBL] [Abstract][Full Text] [Related]
33. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
Sonty S; Mundorf TK; Stewart JA; Stewart WC
Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
[TBL] [Abstract][Full Text] [Related]
34. Treatment of progressive normal-tension glaucoma.
Werner EB
J Glaucoma; 1997 Dec; 6(6):408-11. PubMed ID: 9407370
[No Abstract] [Full Text] [Related]
35. Glaucoma and mortality.
Sharkawi E; Franks W
Ophthalmology; 2008 Jan; 115(1):213-4; author reply 214. PubMed ID: 18166417
[No Abstract] [Full Text] [Related]
36. Fixed-combination brimonidine/timolol as adjunctive therapy to a prostaglandin analog: a 3-month, open-label, replacement study in glaucoma patients.
Nguyen QH; Earl M
J Ocul Pharmacol Ther; 2009 Dec; 25(6):541-4. PubMed ID: 20028261
[TBL] [Abstract][Full Text] [Related]
37. Melatonin and its analog 5-methoxycarbonylamino-N-acetyltryptamine potentiate adrenergic receptor-mediated ocular hypotensive effects in rabbits: significance for combination therapy in glaucoma.
Crooke A; Huete-Toral F; Martínez-Águila A; Martín-Gil A; Pintor J
J Pharmacol Exp Ther; 2013 Jul; 346(1):138-45. PubMed ID: 23591996
[TBL] [Abstract][Full Text] [Related]
38. Recent clinical pearls from clinical trials in glaucoma.
Grover DS; Smith O
Curr Opin Ophthalmol; 2012 Mar; 23(2):127-34. PubMed ID: 22249234
[TBL] [Abstract][Full Text] [Related]
39. A comparison of the fixed combination of latanoprost and timolol with the unfixed combination of brimonidine and timolol in patients with elevated intraocular pressure. A six month, evaluator masked, multicentre study in Europe.
García-Sánchez J; Rouland JF; Spiegel D; Pajic B; Cunliffe I; Traverso C; Landry J
Br J Ophthalmol; 2004 Jul; 88(7):877-83. PubMed ID: 15205229
[TBL] [Abstract][Full Text] [Related]
40. Brinzolamide/brimonidine (Simbrinza) for glaucoma.
Med Lett Drugs Ther; 2013 Jul; 55(1421):57-8. PubMed ID: 23863917
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
